VIA
FLGT icon

Vident Investment Advisory’s Fulgent Genetics FLGT Stock Holding History

Vident Investment Advisory’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-38,776
Closed -$1.41M – 1232
2022
Q3 		$1.41M Sell
38,776
-2,336
-6% -$117K 0.05% 474
2022
Q2 		$2.24M Buy
41,112
+3,072
+8% +$169K 0.07% 347
2022
Q1 		$2.37M Buy
38,040
+14,577
+62% +$960K 0.06% 383
2021
Q4 		$2.36M Buy
23,463
+894
+4% +$78.6K 0.06% 376
2021
Q3 		$2.03M Buy
+22,569
New +$2.05M 0.06% 403

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Vident Investment Advisory's FLGT Position: Q4 2022 in Review

Vident Investment Advisory sold out of Fulgent Genetics (FLGT) in Q4 2022, closing a stake of 38,776 shares — an estimated $1.41M sold.

Vident Investment Advisory first reported a position in FLGT in Q3 2021 and held it in 5 quarters. The position peaked at $2.37M in Q1 2022. 224 funds tracked by Wall St. Rank hold FLGT as of Q4 2022.

  • Vident Investment Advisory reported no remaining Fulgent Genetics position as of Q4 2022 after selling out during the quarter.
  • Vident Investment Advisory sold 38,776 Fulgent Genetics shares in Q4 2022, an estimated $1.41M.
  • Vident Investment Advisory first reported a position in Fulgent Genetics in Q3 2021 and held it in 5 quarters.
  • Vident Investment Advisory's Fulgent Genetics position peaked at $2.37M in Q1 2022.
  • 224 funds tracked by Wall St. Rank held Fulgent Genetics as of Q4 2022.

Based on Vident Investment Advisory's 13F filing for Q4 2022, filed 14 Feb 2023.